Addex Therapeutics Ltd (ADXN) Price Prediction & ForecastADXNAddex Therapeutics Ltd

Alphio's ADXN stock price prediction model matches the current Addex Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.84 (-1.62%). The 1-week path is $2.94 (+1.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Addex Therapeutics Ltd (ADXN) is currently not a strong buy due to its ongoing financial challenges and negative performance trends. The stock has experienced a year-to-date decline of 64.28% and a 52-week low of 2.56, indicating significant volatility. Although the RSI is at 41.217, suggesting it is nearing oversold conditions, the forward P/E ratio is 0, indicating no earnings expected in the near term. The company has reported a net loss of CHF 3.46 million for H1 2026, which is wider than the previous year, and its gross margin has fluctuated, showing instability. The main risk is the high net loss per share of CHF 0.03, which raises concerns about profitability moving forward.

Addex Therapeutics Ltd (ADXN) last closed at $2.8901, losing -0.34%. These facts feed the 1-day and 1-week ADXN price prediction above.